MYCN AMPLIFICATION PREDICTED A WORSE PROGNOSIS IN PATIENTS WITH LOWER-GRADE IDH-MUTANT GLIOMAS AND WAS RELATED TO THE EPITHELIOID HISTOLOGICAL FEATURES

被引：0
|
作者：
Xi, S. [1 ]
Xie, X. [1 ]
Qin, Y. [1 ]
Lu, J. [1 ]
机构：
[1] Sun yat sen Univ Canc Ctr, Guangzhou, Peoples R China
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.346
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P18.30.B
引用
收藏
页码：V104 / V104
页数：1
相关论文
共 50 条
  • [31] A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
    Wetzel, Ethan A.
    Nohman, Amin I.
    Hsieh, Annie L.
    Reuss, David
    Unterberg, Andreas W.
    Eyuepoglu, Ilker Y.
    Hua, Lingyang
    Youssef, Gilbert
    Wen, Patrick Y.
    Cahill, Daniel P.
    Jungk, Christine
    Juratli, Tareq A.
    Miller, Julie J.
    JOURNAL OF NEURO-ONCOLOGY, 2025, 171 (02) : 373 - 381
  • [32] IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis
    Nakasu, Satoshi
    Deguchi, Shoichi
    Nakasu, Yoko
    BRAIN TUMOR PATHOLOGY, 2023, 40 (03) : 143 - 157
  • [33] The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification
    Ninatti, Gaia
    Pini, Cristiano
    Bono, Beatrice Claudia
    Gelardi, Fabrizia
    Antunovic, Lidija
    Fernandes, Bethania
    Sollini, Martina
    Landoni, Claudio
    Chiti, Arturo
    Pessina, Federico
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 473 - 481
  • [34] The Overexpression of RTN4 Significantly Associated With an Unfavourable Prognosis in Patients With Lower-Grade Gliomas
    Feng, Jing
    Zhao, Lin
    Chen, Huiyan
    Lin, Jianhai
    Shang, Mingchao
    Xu, Baoqing
    Wang, Xinpeng
    Ma, Danyu
    Zhou, Jinping
    Zhao, Hu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (04)
  • [35] QUANTITATIVE MR PARAMETERS FOR THE PREDICTION OF EGFR AMPLIFICATION AND THE TERT PROMOTER MUTATION STATUS OF IDH-WILDTYPE LOWER-GRADE GLIOMAS
    Park, Yae Won
    Ahn, Sung Soo
    Kim, Eui Hyun
    Kang, Seok-Gu
    Chang, Jong Hee
    Kim, Se Hoon
    Lee, Seung-Koo
    NEURO-ONCOLOGY, 2020, 22 : 155 - 155
  • [36] The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature
    Lu, Victor M.
    O'Connor, Kyle P.
    Shah, Ashish H.
    Eichberg, Daniel G.
    Luther, Evan M.
    Komotar, Ricardo J.
    Ivan, Michael E.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (02) : 221 - 229
  • [37] The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature
    Victor M. Lu
    Kyle P. O’Connor
    Ashish H. Shah
    Daniel G. Eichberg
    Evan M. Luther
    Ricardo J. Komotar
    Michael E. Ivan
    Journal of Neuro-Oncology, 2020, 148 : 221 - 229
  • [38] IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification (vol 23, pg 955, 2021)
    Berzero, Giulia
    Di Stefano, Anna Luisa
    Ronchi, Susanna
    Bielle, Franck
    Villa, Chiara
    Guillerm, Erell
    Capelle, Laurent
    Mathon, Bertrand
    Laurenge, Alice
    Giry, Marine
    Schmitt, Yohann
    Marie, Yannick
    Idbaih, Ahmed
    Hoang-Xuan, Khe
    Delattre, Jean-Yves
    Mokhtari, Karima
    Sanson, Marc
    NEURO-ONCOLOGY, 2023, 25 (05) : 1011 - 1012
  • [39] Prognosis of patients with IDH-wildtype and IDH-mutant diffuse gliomas: data from the King Hussein Cancer Center (2014-2019)
    Al-Hussaini, M.
    Al-Ghnimat, S.
    Sultan, H.
    Amarin, J. Z.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S46 - S46
  • [40] Characteristics and patterns of care of high-grade IDH-mutant gliomas in elderly patients: A French POLA network study
    Montegut, C.
    Guillamo, J. -S.
    Ducray, F.
    Dehais, C.
    Chinot, O.
    Moyal, E. L. Cohen-Jonathan
    Le Rhun, E.
    Loiseau, H.
    Appay, R.
    Figarella-Branger, D.
    Delattre, J. -Y.
    Tabouret, E.
    ANNALS OF ONCOLOGY, 2019, 30
12345